NO20021295L - Nikotinsyreacetylcholin-reseptor - Google Patents

Nikotinsyreacetylcholin-reseptor

Info

Publication number
NO20021295L
NO20021295L NO20021295A NO20021295A NO20021295L NO 20021295 L NO20021295 L NO 20021295L NO 20021295 A NO20021295 A NO 20021295A NO 20021295 A NO20021295 A NO 20021295A NO 20021295 L NO20021295 L NO 20021295L
Authority
NO
Norway
Prior art keywords
nikotinsyreacetylcholin
receptor
nikotinsyreacetylcholin receptor
Prior art date
Application number
NO20021295A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021295D0 (no
Inventor
Jeffrey Roland Yon
Christopher James Grantham
Paulus Johanne Groot-Kormelink
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0002431A external-priority patent/GB0002431D0/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20021295D0 publication Critical patent/NO20021295D0/no
Publication of NO20021295L publication Critical patent/NO20021295L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Psychology (AREA)
NO20021295A 1999-09-15 2002-03-15 Nikotinsyreacetylcholin-reseptor NO20021295L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15394899P 1999-09-15 1999-09-15
GB0002431A GB0002431D0 (en) 2000-02-02 2000-02-02 Nicotinic acetylcholine receptor
PCT/EP2000/009115 WO2001019973A2 (en) 1999-09-15 2000-09-14 Nicotinic acetylcholine receptor: alpha10 subunit

Publications (2)

Publication Number Publication Date
NO20021295D0 NO20021295D0 (no) 2002-03-15
NO20021295L true NO20021295L (no) 2002-05-14

Family

ID=26243551

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021295A NO20021295L (no) 1999-09-15 2002-03-15 Nikotinsyreacetylcholin-reseptor

Country Status (10)

Country Link
US (1) US20060127914A1 (ja)
EP (1) EP1218502A2 (ja)
JP (1) JP2003509045A (ja)
KR (1) KR20020059331A (ja)
AU (1) AU780460B2 (ja)
CA (1) CA2384294A1 (ja)
IL (1) IL148667A0 (ja)
NO (1) NO20021295L (ja)
NZ (1) NZ516504A (ja)
WO (1) WO2001019973A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1190708A1 (en) * 2000-09-21 2002-03-27 Tinnitus Forschungs- und Entwicklungs GmbH Medical use of substances
US8497081B2 (en) 2004-02-24 2013-07-30 Allergan, Inc. Botulinum toxin screening assays
ATE533853T1 (de) * 2004-02-24 2011-12-15 Allergan Inc Botulinumtoxin-screening-assays
US9284358B2 (en) 2006-07-18 2016-03-15 University Of Utah Research Foundation Conotoxin peptides
CA2657532C (en) * 2006-07-18 2019-06-18 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
JP7169267B2 (ja) * 2016-09-08 2022-11-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 重症筋無力症を診断および治療するためのペプチドおよびその使用
WO2020234179A1 (en) * 2019-05-17 2020-11-26 Janssen Pharmaceutica Nv Expression systems for the alpha 9/alpha 10 nicotinic acetylcholine receptor and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683912A (en) * 1994-07-21 1997-11-04 The Salk Institute For Biological Studies Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit

Also Published As

Publication number Publication date
AU7520100A (en) 2001-04-17
WO2001019973A3 (en) 2001-09-27
NO20021295D0 (no) 2002-03-15
AU780460B2 (en) 2005-03-24
CA2384294A1 (en) 2001-03-22
IL148667A0 (en) 2002-09-12
US20060127914A1 (en) 2006-06-15
NZ516504A (en) 2003-09-26
EP1218502A2 (en) 2002-07-03
KR20020059331A (ko) 2002-07-12
JP2003509045A (ja) 2003-03-11
WO2001019973A2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
ID26447A (id) Turunan eritropoietin
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
DE50010505D1 (de) Gurtaufrollersystem
NO20020229L (no) Nedihullsomlöpsventil
NO20022856L (no) Adamtanderivater
DE60009430D1 (de) Türtülle
NO20020487D0 (no) 2-Pyrazolin-5-oner
DE60008638D1 (de) Förderbandabstreicher
DE60001283D1 (de) Celluloseetherfilme
PT1221171E (pt) Contactor - disjuntor
DE60012922D1 (de) Pulveraufschlämmungsüberzugszusammensetzung
NO20022650L (no) 4-Pyridyl-N-acyl-L-fenylalaniner
DE60015794D1 (de) Kompositverschlusskappe
NO20013997D0 (no) Reseptoranalyse
DE50007953D1 (de) Beleuchtungsanordung
DE60012888D1 (de) Mevinolinderivate
ID30214A (id) Turunan resorsinol
DE50000805D1 (de) Aufsitzspanner
DE60028852D1 (de) Fixiervorrichtung
NO20021295D0 (no) Nikotinsyreacetylcholin-reseptor
NO20022927L (no) Substituerte pyrrazoler
NO20021850D0 (no) Hygromycinderivater
NO20005774D0 (no) Leketöyanordning
PT1202966E (pt) Piperidino-alcoois

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application